Interstitial pulmonary fibrosis
Interstitial Pulmonary Fibrosis is a chronic lung disease characterized by scarring of the lung tissue between the air sacs, leading to shortness of breath and functional disability. The condition is part of a larger group of diseases, known as interstitial lung diseases, which includes over 200 different conditions.
Causes[edit | edit source]
The exact cause of Interstitial Pulmonary Fibrosis is unknown, but it is believed to occur when the lung's repair mechanism responds to a microscopic injury to the lung tissue. This can be caused by various factors such as viral infections, environmental pollutants, radiation therapy, chronic aspiration, and certain medications.
Symptoms[edit | edit source]
The symptoms of Interstitial Pulmonary Fibrosis include shortness of breath, cough, and fatigue. As the disease progresses, these symptoms may become more severe, and additional symptoms such as weight loss, clubbing of the fingers and toes, and cyanosis (bluish discoloration of the skin and mucous membranes) may develop.
Diagnosis[edit | edit source]
The diagnosis of Interstitial Pulmonary Fibrosis is often made based on the patient's history, physical examination, and the results of pulmonary function tests. Additional tests such as a chest X-ray, CT scan, and lung biopsy may also be performed.
Treatment[edit | edit source]
While there is no cure for Interstitial Pulmonary Fibrosis, treatments are available to help manage symptoms and improve quality of life. These may include medications, pulmonary rehabilitation, oxygen therapy, and in severe cases, lung transplantation.
Prognosis[edit | edit source]
The prognosis for individuals with Interstitial Pulmonary Fibrosis varies widely. Some people may experience a slow progression of the disease, while others may experience a rapid progression. Factors that can affect prognosis include the person's age, overall health, and response to treatment.
See Also[edit | edit source]
Interstitial pulmonary fibrosis Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD